|
HS Code |
922897 |
| Generic Name | Liothyronine Sodium |
| Brand Names | Cytomel, Triostat |
| Chemical Formula | C15H11I3NNaO4 |
| Drug Class | Thyroid hormone |
| Route Of Administration | Oral, intravenous |
| Primary Use | Treatment of hypothyroidism |
| Mechanism Of Action | Synthetic form of triiodothyronine (T3) that increases metabolic rate |
| Half Life | Approximately 1 to 2 days |
| Pregnancy Category | FDA Category A |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F), protected from light and moisture |
As an accredited Liothyronine Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White and blue box labeled “Liothyronine Sodium 25 mcg,” containing 100 tablets in a blister pack, with dosage instructions printed. |
| Shipping | Liothyronine Sodium is shipped in secure, tightly sealed containers to protect against moisture and contamination. It is typically transported at controlled room temperature, away from light and incompatible substances. Proper labeling and documentation are provided to ensure compliance with regulatory guidelines for pharmaceutical chemicals during transit and delivery. |
| Storage | Liothyronine Sodium should be stored at room temperature, typically between 20°C and 25°C (68°F and 77°F), in a tightly closed container. Protect it from light, moisture, and excessive heat. Store away from incompatible substances and keep out of reach of children. Ensure the storage area is dry and well-ventilated to maintain the chemical’s stability and effectiveness. |
Applications of Liothyronine Sodium in Industrial ManufacturingAs a direct manufacturer of Liothyronine Sodium, we supply this specialty ingredient to regulated industries where precision in pharmaceutical-grade hormone formulation is required. The following real-world application arenas represent downstream production environments where our material is reliably used as a critical active or intermediate component, governed by strict compliance criteria and validated production methodologies. 1. Pharmaceutical Thyroid Hormone Tablet ManufacturingMajor generic and branded medicine producers use our Liothyronine Sodium to formulate oral thyroid hormone tablets indicated for disorders such as hypothyroidism and certain types of goiter. The active is carefully blended with microcrystalline cellulose and other excipients under controlled conditions in tableting plants operating under pharmaceutical cGMP. Every batch undergoes potency, purity, and content uniformity testing to meet national and international pharmacopoeial monographs before compression, coating, and packaging are finalized. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Injectable Thyroid Hormone Solution ProductionRegulated sterile manufacturing units employ our material as the active ingredient in ampoule and vial preparations for parenteral thyroid hormone replacement, indicated in acute hypothyroid states or for diagnostic purposes. Formulation includes precise dissolution, sterile filtration, and aseptic filling, with rigorous environmental and batch control to prevent contamination or potency loss throughout. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Bulk Hormone Powder Filling for Compounding PharmaciesLicensed pharmaceutical compounding operations purchase our high-purity Liothyronine Sodium in approved bulk packaging to prepare customized medication in response to specialist prescriptions for thyroid disorders not addressed by standard dosage forms. Pharmacists reconstitute, blend, and dispense precisely dosed capsules or oral suspensions under regulated compounding protocols, ensuring traceability and label accuracy. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Diagnostic Radiopharmaceutical Synthesis for Clinical Isotope LabsMedical isotope production facilities utilize Liothyronine Sodium as a complexation agent or metabolic stimulant in the labeling and formulation of radiopharmaceuticals used for thyroid function assessment scans. Controlled introduction occurs during the radiolabeling step, subject to specific radiochemical purity and stability requirements, with rigorous batch documentation for clinical traceability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Liothyronine Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Liothyronine Sodium stands out as a cornerstone material for those working with thyroid hormone replacements. Our focus always begins with the chemical itself: we produce pure, pharmaceutical-grade Liothyronine Sodium, known in markets by its widely recognized standard—CAS number 55-06-1. The material forms a white, odorless powder with consistent particle size and proven solubility in both water and dilute alcohol solutions. We pay close attention to the molecular configuration, ensuring all product lots meet the established monograph standards for recognized pharmacopeia quality, with each batch produced and tested entirely in facilities that operate under strict regulatory oversight.
Each run of Liothyronine Sodium on our production line begins with tight process control. No shortcuts—raw materials are sourced after multiple quality verification steps. For every kilogram we produce, our laboratory analysts carry out tests for identification, loss on drying, related substances, and assay. It’s impossible to talk about high-purity thyroid hormones without considering contaminants and impurities. We keep residual solvents down to negligible levels, regularly receiving feedback from clients in regulated markets about the difference this makes in their own downstream production. The product’s particle size—typically standardized so flow properties remain consistent in tableting and encapsulation—lets formulation scientists work with a starting ingredient that saves time during blending and compaction.
Making Liothyronine Sodium comes with a set of challenges that other common APIs do not present. For example, every batch must demonstrate uniform potency across the entire lot, which means our operators continuously monitor both the reactants and intermediates from the very start of synthesis. We take special care during crystallization to prevent formation of aggregates. These can interfere with mixing accuracy downstream. Over the years, process engineers have tweaked temperature controls and filtration methods to keep batch-to-batch variation at an absolute minimum. Our manufacturing teams have gained experience in addressing even minor deviations, like micro-particle formation which, if not caught, can cause dissolution inconsistencies when the product goes downstream. We know the product not just by numbers, but by how it behaves on the line: a batch that flows poorly, that clumps, or that resists dissolution gets flagged long before packaging, saving time—and headaches—later for formulators.
Clinicians and pharmacists depend on quality and predictability, since patients rely on Liothyronine Sodium to manage hypothyroid conditions, especially when standard thyroxine treatments are not suitable. Our production approach prioritizes high assay results, keeping the active content consistently between 97-103%. The smallest deviation can result in major clinical impact because thyroid hormones have a narrow therapeutic window. Having witnessed our shipments being used in a variety of hospital and specialist settings, we have seen how stable, high-purity material improves both dosing flexibility and shelf life. Pharmacies draw confidence from being able to measure reproducible results in extemporaneously compounded preparations, and patients benefit as a result.
Liothyronine Sodium sets itself apart from Levothyroxine Sodium (T4) in terms of physiological effect and chemical behavior. While Levothyroxine delivers a longer half-life, Liothyronine acts much more rapidly, producing clinical benefits in shorter periods. This rapid onset fits certain clinical needs, such as acute treatment scenarios or in patients with impaired T4-to-T3 conversion. From a production viewpoint, handling Liothyronine requires even more careful environmental control. It absorbs moisture more readily, and its crystalline powder can develop static issues if not controlled—something we have addressed by redesigning our milling and drying processes over the years.
There are natural thyroid extracts on the market, but these present more variability batch to batch, not to mention potential allergenic proteins. Synthetic Liothyronine Sodium, on the other hand, offers unmatched purity and batch reproducibility. Those who have worked with natural extracts have often commented on the difference after switching to well-made, synthetic product: the workflow becomes more streamlined, fewer surprises appear in dissolution or potency, and, ultimately, patient outcomes remain more predictable.
Specifications come from daily interaction with our partners. In some countries, the demand focuses on highly granulated powders, helping with direct compression tableting. In others, fine powder for quick dissolution becomes the top request. Our technical team interacts directly with downstream users, tweaking drying times, and adjusting mesh sieves to fulfill real formulation needs. Feedback from compounding pharmacists has been fundamental in rearranging how we manage particle sizing and storage. Some larger generic manufacturers have even visited our site to see the production up close—they’ve seen firsthand that planning for final dosage form requirements starts on the chemical plant floor, not in the lab.
Part of adjusting specifications means running stability studies that match real shipment conditions. Our teams mimic temperature and humidity fluctuations typical of transportation across multiple regions. Dry powder sent to a humid location must retain potency, resist caking, and flow easily into blending hoppers. We’ve invested in double-walled containers and low-permeation barrier bags, learning from occasional past issues with minor moisture infiltration. On-site storage conditions receive ongoing monitoring, ensuring stock always leaves the plant within the optimal range for moisture content and color.
Having supplied Liothyronine Sodium to regulated markets for many years, we develop our process with a high level of traceability. Each lot has a documented history, from synthesis through packaging. Reprocessing is not an option—batches are either compliant or destroyed. Regulatory auditors review our workflows regularly, and customer audits sometimes yield suggestions that have led to measurable improvements, such as adjusting inspection intervals or deploying automated impurity detection technology. We never treat quality testing as a checklist but as a feedback loop with our own operators, customer quality managers, and external regulatory experts. Sometimes, this means spending a few extra days in analysis to ensure that borderline results receive further confirmation; customers expect consistency, and nothing gets shipped without multiple signatures on the release form.
Manufacturing Liothyronine Sodium does not happen in isolation. The relationships we build with suppliers and downstream customers create a continuous improvement cycle. Suppliers of starting materials know they must provide not just a certificate but also periodic process samples, which we retest before each major production run. We conduct audits—sometimes flying in our own technologists to source countries—making sure precursor suppliers maintain the same standards that we impose on our own lines.
On the customer side, we field questions from both formulation scientists working with the material for the first time and those experienced in scaling up solid dosage manufacturing. We receive feedback on mixing challenges, dissolve kinetics, color changes, and unexpected flow properties. By addressing these issues collectively—sometimes even including video walkthroughs of our process in customer trainings—we help customers adopt more robust compounding and manufacturing solutions. The conversation never ends at delivery. Some of our closest partnerships started with a call about an error or a product fit concern, and have evolved into multi-year co-development projects where both sides learn from each other.
A major pain point in thyroid API manufacturing remains in achieving the required purity and keeping that purity stable until end use. Customers demand a narrow range for related substances because many have had to discard lots due to unknown peaks or off-spec results in older supply chains. We understand how frustrating it gets to troubleshoot unexplained assay drift or formation of visible spots in the powder after only a few weeks of storage. So, our lab teams performed extended stability studies—sometimes crossing two or three climactic zones within the same test run—pinpointing how minor changes in process could prevent instability.
Our team switched to low-shear blending and updated packaging immediately on learning about electrostatic accumulation, which, in rare cases, led to local aggregation or settling in finished drug products. Today, we keep batch logs not just as regulatory fodder; these historical quality records serve as our guidebook for process refinements and problem solving.
The equipment we put in place for Liothyronine Sodium differs from what we use for other drug substances. Glass-lined reactors, anti-static finishes, and closed transfer systems play essential roles. For drying, we rely on vacuum tray driers with tight temperature programming. Small tweaks—like periodic filter paper checks or additional in-line sieving—have ended up making a noticeable difference.
A few years ago, we experimented with automated weigh-dosing to resolve a minor, recurring variance in filling weights. Automation cut the complaint rate, and it freed up staff to focus on more critical, hands-on tasks like real-time process monitoring. Our production crew knows to step in early if they see an issue, not wait for an end-of-shift report. This direct approach—having boots on the factory floor and experienced eyes on the process—has kept our products reliable, even at higher volumes.
Compared to many pharmaceutical ingredients, Liothyronine Sodium behaves differently throughout formulation and final product development. Its fast onset in therapy sometimes requires careful titration, and pharmacists working with this powder must measure doses precisely. That's why we consistently train sales support and technical staff on the nuances of the product’s release profile and dissolution behavior.
Levothyroxine, the T4 analog, offers longer-term stability. Some of our clients, previously dedicated to Levothyroxine, comment that switching to Liothyronine opens up new therapeutic options. Those with more experience in hospital pharmacy have pointed out that Liothyronine batches from bulk suppliers sometimes come in inconsistent lots, showing color shifts over time, slight odor variations, or even clumps that are hard to blend out. Our process eliminates these headaches as much as technically possible. In side-by-side comparisons, customers have shown us their finished tablets with our material—lighter color, faster wetting, and easier mixing were the main improvements they noted on their production lines.
Liothyronine Sodium holds a listing on the World Health Organization’s Model List of Essential Medicines. This carries real consequences for manufacturers. We align with global pharmacopeias and regional regulatory guidelines, reviewing updates and quickly implementing changes to analytical methods or impurity monitoring. Our regulatory teams communicate openly with both EU and US customers, providing documentation and validation reports. Meeting these standards means more than just ticking boxes—it’s an ongoing process of adjusting methods, training staff, and retaining data for many years.
We’ve been through more than one global recall initiated by other players in the supply chain, which hits the industry hard. As a result, we have introduced redundancy and extra certifications in our raw material vetting and have worked with international auditors to keep up with changes in both documentation and technical standards. Staying honest about where problems begin has spared us from more significant issues later on, and customers tell us they value the transparency.
Clients sometimes approach us with requests that force us to rethink long-standing practices. For example, a customer in a high-humidity region struggled with caking, even after moving to room dehumidifiers and silica gel pouches. During a follow-up, our technical support team suggested alternate packaging and shorter-term lot supply, which solved the issue. In another case, a generic formulator ran into flow problems when switching tablet granulation processes. We provided fresh analytical data on particle size distributions and ended up working together to establish a custom blend suitable for their set-up.
Our team deals with these real problems every week, and experience has taught us that quick, surface-level fixes rarely last. Repeating the same test in different conditions or using alternate analytical reagents sometimes uncovers problems missed by standard monograph methods. This proactive approach makes sure that the end product meets not just published specs but real-world reliability in the field.
Manufacturing an active pharmaceutical ingredient like Liothyronine Sodium involves both chemical safety and environmental responsibility. We maintain strong containment controls and waste handling procedures, not just for regulatory compliance but also to protect our workers and the local environment. Each step of synthesis generates specific byproducts. We track all effluent and manage waste with dedicated treatment systems, operating in close coordination with local authorities. Our operators receive training not just in safe handling but in recognizing early signs of equipment wear or potential accidental exposure.
Over the years, we invested in air quality controls, solvent reclamation, and energy-saving initiatives to minimize our footprint. Sustainability efforts are no longer an add-on. They define our way of doing business, and, increasingly, our customers expect suppliers to meet higher environmental standards than ever before. Regular dialogues with partners and staff members in the plant keep the focus on finding safer, greener approaches to every stage of production.
As demand grows worldwide for guaranteed supply and accredited quality in thyroid hormones, manufacturers face new pressures. We have learned not to stand still—revisiting process maps, expanding monitoring, and driving continual improvement are ongoing efforts. Investing in staff training, analytical instrumentation, and safe, robust plant infrastructure remains essential. Each shipment of Liothyronine Sodium reflects not only current global standards but also the collective effort and day-to-day decisions of everyone involved on the production side.
Customer partnerships inform almost every change we make. Whether feedback arrives from a hospital pharmacist compounding a lifesaving dose, or a solid dose manufacturer scaling up tablets for a national health contract, we know our material needs to work every time. Quality promise is not just a slogan; it’s based on what we observe daily, test after test, batch after batch.
Making Liothyronine Sodium isn’t only about chemical synthesis. It reflects a chain of trust—from raw material suppliers, through every plant operator, to patients and clinicians relying on a stable product. Real success comes from close attention to process, understanding customer environments, and never ignoring feedback from the field. Day after day, this is what shapes our Liothyronine Sodium production—and what makes the difference between good and exceptional material for everyone who depends on it.